BackOncopeptides AB (publ) Overview
Oncopeptides AB (publ)

Oncopeptides AB (publ) PEG Ratio

Valuation check: ONPPF's PEG ratio is 27.04, above the Healthcare sector average of -6.46.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

27.04

PEG Ratio

27.04

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Oncopeptides AB (publ) (ONPPF) FAQ

The latest PEG ratio for ONPPF is 27.04. That is above the Healthcare sector average of -6.46. Investors often review this figure alongside Oncopeptides AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, ONPPF currently prints 27.04 for PEG ratio, while the sector average sits near -6.46. That is roughly 518.4% above the sector mean. Large gaps often invite a closer look at Oncopeptides AB (publ)'s growth, margins, and balance sheet.

A PEG ratio of 27.04 for Oncopeptides AB (publ) is not 'good' or 'bad' on its own. Compare it with the peer average (-6.46) and with ONPPF's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ONPPF's PEG ratio (27.04), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Oncopeptides AB (publ)'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.